Side-effects of amphotericin B lipid complex (Abelcet) in the Scandinavian population.
Furebring
M
M
Oberg
G
G
Sjölin
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000009:adverse effects* / Q000633:toxicity; D000935:Antifungal Agents / Q000009:adverse effects / Q000633:toxicity; D001663:Bilirubin / Q000097:blood; D016026:Bone Marrow Transplantation; D003404:Creatinine / Q000097:blood; D004338:Drug Combinations; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy / Q000208:ethnology / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000009:adverse effects* / Q000633:toxicity; D010715:Phosphatidylglycerols / Q000009:adverse effects* / Q000633:toxicity; D012537:Scandinavian and Nordic Countries / Q000453:epidemiology
D000935:Antifungal Agents; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D000666:Amphotericin B; D003404:Creatinine; D001663:Bilirubin